Methods: The design was a double-blind, placebo-controlled, randomized, multicenter study. 120 patients were included and tested as devised by Steiner. Primary variables were Premenstrual Tension Syndrome self-rating (PMTS-S) and Premenstrual Tension Syndrome observer-rating (PMTS-O). Secondary variables were PMS symptoms evaluated on visual analogue (VAS) scales. Femal tablets 160 mg (twice da...